Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449390) titled 'Drug-drug Interaction Trial of AP31969 and Carbamazepine or Itraconazole' on Feb. 27.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Crossover Assignment. Primary purpose: Other. Masking: None (Open Label).

Primary Sponsor: Acesion Pharma

Condition: Healthy Participants

Intervention: Drug: AP31969 Drug: Carbamazepine

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: March 25, 2026

Target Sample Size: 28

To know more, visit https://clinicaltrials.gov/study/NCT07449390

Disclaimer: Curated by HT Syndication....